| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 06/30/2011 | WO2011076969A1 Multifunctional compounds modifying alzheimer's disease for the treatment of said disease |
| 06/30/2011 | WO2011076237A1 Improved process for the preparation of montelukast and salts thereof |
| 06/30/2011 | WO2011017519A3 Inhibitors of methionine aminopeptidases and methods of treating disorders |
| 06/30/2011 | WO2009001374A3 Preparation of ethyl-3'-[((7-chloro-2-quinolinyl)ethenyl)phenyl]-3-oxopropanoate, a key intermediate for montelukast sodium |
| 06/30/2011 | US20110160458 Process and intermediates for preparing integrase inhibitors |
| 06/29/2011 | EP2338886A2 Naphthalene derivatives |
| 06/29/2011 | EP2337779A2 2-oxo-1,2-dihydro-quinoline modulators of immune function |
| 06/29/2011 | EP1767536B1 Quinolonecarboxylic acid compounds, preparation methods and pharmaceutical uses thereof |
| 06/29/2011 | EP1326834B1 2-substituted heterocyclic compounds |
| 06/29/2011 | EP1233958B1 Inhibitors of histone deacetylase |
| 06/29/2011 | CN101357902B Method for preparing N- formyl-2H-4chloroquinoline derivate |
| 06/28/2011 | US7968721 Coupling a N-phenyl-1-bromo-2-substituted propamide with a substituted hydroxy-, amino-, phosphino-, or seleno- benzene compound; crystallization and filtration; industrial scale, high purity; non-steroidal agonists |
| 06/28/2011 | US7968601 Treating excess cortisol formation; obesity, cardiovascular disorders, glaucoma, osteoporosis, Alzheimer's Disease; antidiabetic agents |
| 06/28/2011 | US7968567 Compounds for the modulation of PPARγ activity |
| 06/28/2011 | US7967872 Azo quinolinium compounds comprising a disulphide/thiol unit, compositions containing same, process for dyeing keratin fibres and device |
| 06/28/2011 | CA2427206C Sulfamides as gamma-secretase inhibitors |
| 06/23/2011 | WO2011074550A1 Method for manufacturing organic electroluminescent element, organic electroluminescent element, display device and illuminating device |
| 06/23/2011 | WO2011073322A1 7-chloro-quinolin-4-amine compounds and uses thereof for the prevention or treatment of diseases involving formation of amyloid plaques and/or where a dysfunction of the app metabolism occurs |
| 06/23/2011 | US20110152529 Transition metal complex, catalyst composition including the same and olefin polymer using catalyst composition |
| 06/23/2011 | US20110152315 Compounds for the treatment of metabolic diseases |
| 06/23/2011 | US20110152301 Compounds that Inhibit HIV Particle Formation |
| 06/23/2011 | US20110152250 Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor and uses thereof |
| 06/22/2011 | EP2336117A1 Heterocyclic compounds for treating retinal diseases |
| 06/22/2011 | EP1613599B8 A process for the preparation of 5-(haloacetyl)-8-(substituted oxy)-(1h)-quinolin-2-ones |
| 06/22/2011 | CN102105485A Selective caspase inhibitors and uses thereof |
| 06/22/2011 | CN102105449A Arylsulfonamide compounds, compositions and methods of use |
| 06/22/2011 | CN102105437A Adamantyl diamide derivatives and uses of same |
| 06/21/2011 | US7964733 to potentiate the effects of the other CNS agents; probes for the localization of cell surface receptors;3-(methylthio)-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide; depression, anxiety, schizophrenia, cognitive disorders, obesity, irritable bowel syndrome, emesis, pre-eclampsia, etc. |
| 06/21/2011 | US7964731 Isotopically marked quinoline derivatives as adenosin A3 receptor ligands |
| 06/21/2011 | US7964730 Amino-substituted ethylamino β2 adrenergic receptor agonists |
| 06/21/2011 | US7964729 Sox-based kinase sensor |
| 06/21/2011 | US7964727 N-({1-[(cis-1,4-dihydroxycyclohexyl)methyl]piperidin-4-yl}methyl)-1-isopropyl-5-methyl-2-oxo-1, 2-dihydroquinoline-3-carboxamide ethanedioate; gastroesophageal reflux disease, non-ulcer dyspepsia, functional dyspepsia, irritable bowel syndrome |
| 06/21/2011 | US7964616 Compounds 679 |
| 06/21/2011 | US7964615 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptor |
| 06/21/2011 | US7964603 Substituted tetrahydro-quinoline-sulfonamide compounds, their preparation and use as medicaments |
| 06/21/2011 | CA2554437C Amide derivatives, process for preparation thereof and use thereof as insecticide |
| 06/21/2011 | CA2460789C Acid amide derivatives, process for their production and pesticides containing them |
| 06/16/2011 | WO2011072241A1 4 -oxo- ih -quinoline- 3 - carboxamides as modulators of atp -binding cassette transporters |
| 06/16/2011 | WO2011070177A2 Methods of facilitating neural cell survival using gdnf family ligand (gfl) mimetics or ret signaling pathway activators |
| 06/16/2011 | WO2011021726A3 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation |
| 06/16/2011 | US20110144344 Fluoridation of iodonium salts |
| 06/16/2011 | US20110144339 Method for producing asymmetric tetrasubstituted carbon atom-containing compound |
| 06/16/2011 | US20110144156 A3 adenosine receptor allosteric modulators |
| 06/16/2011 | US20110144154 Salts of 2-Substituted Quinolines |
| 06/16/2011 | US20110144066 Small molecule inhibitors of the pleckstrin homology domain and methods for using same |
| 06/16/2011 | US20110143337 Unsymmetrical cyanine dimer compounds and their application |
| 06/16/2011 | CA2783934A1 Methods of facilitating neural cell survival using gdnf family ligand (gfl) mimetics or ret signaling pathway activators |
| 06/16/2011 | CA2783314A1 4-oxo-1h-quinoline-3-carboxamides as modulators of atp-binding cassette transporters |
| 06/15/2011 | EP2332918A1 Sulfonamide derivatives of polycyclic dyes for analytical applications |
| 06/15/2011 | EP2332916A2 A process for a preparation of marbofloxacin and intermediate thereof |
| 06/15/2011 | EP2332915A1 Beta2-adrenoceptor agonists |
| 06/15/2011 | EP2332909A1 Hydroxybenzamide derivatives and their use as inhibitors of HSP90 |
| 06/15/2011 | EP2332905A1 BCRP/ABCG3 Inhibitor |
| 06/15/2011 | EP2331498A2 Cold menthol receptor antagonists |
| 06/15/2011 | EP1052254B1 Nitrogenous heterocyclic derivatives and medicine thereof |
| 06/15/2011 | CN1830964B 4-Substituting anilino-3-nitroquinoline compounds, prepn. method and use thereof |
| 06/15/2011 | CN102099338A Heterocyclic derivatives that are used in the treatment of neurodegenerative diseases |
| 06/15/2011 | CN101429156B Novel methods for producing 1,2,3,4-tetrahydrochysene-4,4-dimethyl quinoline and its derivant |
| 06/15/2011 | CN101260077B Quinolin-2-ones derivative, pharmaceutical composition and use thereof |
| 06/15/2011 | CN101225089B Process for the preparation of diisopinocampheylchloroborane |
| 06/15/2011 | CN101177385B Aryl sulfonic acid amides and analogues as well as its purpose in curing neural degeneration disease |
| 06/15/2011 | CN101104598B Process for preparing trans-4-amino-1-cyclohexanecarboxilic acid derivatives |
| 06/14/2011 | US7960553 Reagent for synthesis of para-methoxbenzyl (PMB) ethers and associated methods |
| 06/14/2011 | US7960551 Compound |
| 06/14/2011 | US7960548 Keratinocyte growth factor receptor—tyrosine specific inhibitors for the prevention of cancer metastatis |
| 06/14/2011 | US7960408 Quinolinyl and benzothiazolyl modulators |
| 06/14/2011 | US7960389 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 06/14/2011 | US7960099 White blood cell differentiation reagent containing an asymmetric cyanine fluorescent dye and method of use thereof |
| 06/14/2011 | CA2494962C Tyrosine kinase inhibitors |
| 06/09/2011 | WO2011068561A1 Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| 06/09/2011 | WO2010143168A3 Compounds useful for treating cancer |
| 06/09/2011 | US20110137039 Process for the preparation of montelukast and its salts |
| 06/09/2011 | US20110137038 Synthesis of selected stereoisomers of certain substituted alcohols |
| 06/09/2011 | US20110136863 N-Heterocyclic M1 Receptor Positive Allosteric Modulators |
| 06/09/2011 | US20110136242 Lanthanide Chelates and Use Thereof in Bioanalysis |
| 06/09/2011 | US20110135604 Antiviral compounds |
| 06/09/2011 | CA2778586A1 Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| 06/08/2011 | EP2064185B1 1h-quinolin-4-one compounds, with affinity for the gaba receptor, processes, uses and compositions |
| 06/08/2011 | CN1926097B Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as FAAH enzyme inhibitors |
| 06/08/2011 | CN102089283A Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group |
| 06/08/2011 | CN102088851A Chemical compounds |
| 06/08/2011 | CN102086211A Aromatic heterocyclic compounds serving as protein kinase inhibitor |
| 06/08/2011 | CN102086184A 5-fluorine-substituted 4-hydroxyl-3,4,5,6-tetrahydro-2H-pyrane-2-ketone compound and preparation method thereof |
| 06/08/2011 | CN102086155A Method for synthesizing amine, alcohol, olefin and alkane through catalytic reduction by using supported gold |
| 06/08/2011 | CN102086143A Method for synthesizing amine by catalytically reducing nitro compound by supported gold |
| 06/08/2011 | CN101602723B Preparation method of 2-methyl-8-aminoquinoline |
| 06/08/2011 | CN101544601B Method for synthesizing 5,6,7,8-tetrahydroquinoline |
| 06/08/2011 | CN101337932B Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| 06/08/2011 | CN101212972B 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility |
| 06/08/2011 | CN101203522B Antineoplastic compounds and pharmaceutical compositions thereof |
| 06/08/2011 | CN101115748B Acetamide compounds as fungicides |
| 06/07/2011 | US7956189 Maleate, tosylate, fumarate and oxalate salts of 5-(1-(S)-amino-2-hydroxyethyl)-N-[(2,4-difluorophenyl)-methy]-2-[8-methoxy-2-(triflouromethy)-5-quinoline]-4-oxazolecarboxamide and preparation process therefore |
| 06/07/2011 | US7956188 N-substituted-2-alkylthio-2-(substituted aryloxy and heteroaryloxy)alkylamides and their sulphinyl and sulphonyl derivatives such as 2-(3,5-dichlorophenoxy)-2-methylthio-N-2-methylprop-2-yl acetamide; fungal infections of plants |
| 06/07/2011 | CA2562130C 2-propene-1-ones as hsp 70 inducers |
| 06/03/2011 | WO2011064249A1 Synthesis of acetoxyacetaldehyde |
| 06/02/2011 | US20110130436 Caspase inhibitors and uses thereof |
| 06/02/2011 | US20110130305 Novel dyes and compositions, and processes for using same in analysis of protein aggregation and other applications |
| 06/01/2011 | EP2327683A1 Synthesis of acetoxyacetaldehyde |
| 06/01/2011 | EP2326643A2 Benzoquinoline inhibitors of vesicular monoamine transporter 2 |
| 06/01/2011 | EP1386608B1 Remedial agent for glomerular disease |